{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:36:39Z","timestamp":1760783799311},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00431-014-2314-6","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T02:20:25Z","timestamp":1396837225000},"page":"1691-1694","source":"Crossref","is-referenced-by-count":7,"title":["Neurofibromatosis type 1 (NF1) with an unusually severe phenotype due to digeny for NF1 and ryanodine receptor 1 associated myopathy"],"prefix":"10.1007","volume":"173","author":[{"given":"Florence","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Kana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Capone","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Boltshauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Jane","family":"Rushing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"issue":"Suppl 2","key":"2314_CR1","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.nmd.2012.08.001","volume":"22","author":"PG Carlier","year":"2012","unstructured":"Carlier PG, Mercuri E, Straub V (2012) Applications of MRI in muscle diseases. Neuromuscul Disord 22(Suppl 2):S41","journal-title":"Neuromuscul Disord"},{"key":"2314_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81\u201388","journal-title":"J Med Genet"},{"key":"2314_CR3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nmd.2007.12.005","volume":"18","author":"M Filosto","year":"2008","unstructured":"Filosto M, Tonin P, Scarpelli M, Savio C, Greco F, Mancuso M, Vattemi G, Govoni V, Rizzuto N, Tupler R, Tomelleri G (2008) Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype. Neuromuscul Disord 18:204\u2013209","journal-title":"Neuromuscul Disord"},{"key":"2314_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.nmd.2011.07.011","volume":"22","author":"M Jokela","year":"2012","unstructured":"Jokela M, Udd B, Paivarinta M (2012) Double trouble: spinal muscular atrophy type II and seropositive myasthenia gravis in the same patient. Neuromuscul Disord 22:129\u2013130","journal-title":"Neuromuscul Disord"},{"key":"2314_CR5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneurol.2011.188","volume":"68","author":"A Klein","year":"2011","unstructured":"Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, Pane M, Wraige E, Schara U, Straub V, Mercuri E, Muntoni F (2011) Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol 68:1171\u20131179","journal-title":"Arch Neurol"},{"key":"2314_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","volume":"33","author":"A Klein","year":"2012","unstructured":"Klein A, Lillis S, Munteanu I, Scoto M, Zhou H, Quinlivan R, Straub V, Manzur AY, Roper H, Jeannet PY, Rakowicz W, Jones DH, Jensen UB, Wraige E, Trump N, Schara U, Lochmuller H, Sarkozy A, Kingston H, Norwood F, Damian M, Kirschner J, Longman C, Roberts M, Auer-Grumbach M, Hughes I, Bushby K, Sewry C, Robb S, Abbs S, Jungbluth H, Muntoni F (2012) Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum Mutat 33:981\u2013988","journal-title":"Hum Mutat"},{"key":"2314_CR7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpeds.2010.10.001","volume":"158","author":"J Lorenzo","year":"2011","unstructured":"Lorenzo J, Barton B, Acosta MT, North K (2011) Mental, motor, and language development of toddlers with neurofibromatosis type 1. J Pediatr 158:660\u2013665","journal-title":"J Pediatr"},{"key":"2314_CR8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.nmd.2011.06.925","volume":"21","author":"L Maggi","year":"2011","unstructured":"Maggi L, Scoto M, Cirak S, Feng L, Lillis S, Cullup T, Robb S, Manzur A, Sewry CA, Abbs S, Jungbluth H, Muntoni F (2011) Congenital myopathies\u2014clinical features and frequency of individual subtypes diagnosed in a five-year period: the UK experience. Neuromuscul Disord 21:691\u2013691","journal-title":"Neuromuscul Disord"},{"key":"2314_CR9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","volume":"47","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Hogel J, Spori H, Cooper DN, Kehrer-Sawatzki H (2010) Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4\u00a0Mb type-1 NF1 deletions. J Med Genet 47:623\u2013630","journal-title":"J Med Genet"},{"key":"2314_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajmg.a.35718","volume":"161","author":"TM Muram","year":"2013","unstructured":"Muram TM, Stevenson DA, Watts-Justice S, Viskochil DH, Carey JC, Mao R, Jackson B (2013) A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1. Am J Med Genet A 161:467\u2013472","journal-title":"Am J Med Genet A"},{"key":"2314_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpn.2010.04.003","volume":"15","author":"R Pandey","year":"2011","unstructured":"Pandey R, Chandratre S, Roberts A, Dwyer JS, Sewry C, Quinlivan R (2011) Central core myopathy with RYR1 mutation masks 5q spinal muscular atrophy. Eur J Paediatr Neurol 15:70\u201373","journal-title":"Eur J Paediatr Neurol"},{"key":"2314_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.nmd.2011.12.001","volume":"22","author":"G Ricci","year":"2012","unstructured":"Ricci G, Scionti I, Ali G, Volpi L, Zampa V, Fanin M, Angelini C, Politano L, Tupler R, Siciliano G (2012) Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: further evidence for \u201cdouble trouble\u201d overlapping syndromes. Neuromuscul Disord 22:534\u2013540","journal-title":"Neuromuscul Disord"},{"key":"2314_CR13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2008.06.387","volume":"18","author":"S Rudnik-Schoneborn","year":"2008","unstructured":"Rudnik-Schoneborn S, Weis J, Kress W, Hausler M, Zerres K (2008) Becker\u2019s muscular dystrophy aggravating facioscapulohumeral muscular dystrophy\u2013double trouble as an explanation for an atypical phenotype. Neuromuscul Disord 18:881\u2013885","journal-title":"Neuromuscul Disord"},{"key":"2314_CR14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"Neurofibromatosis. Conference statement","year":"1988","unstructured":"Neurofibromatosis. Conference statement (1988) National Institutes of Health Consensus Development Conference. Arch Neurol 45:575\u2013578","journal-title":"Arch Neurol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2314-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-014-2314-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2314-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:32:00Z","timestamp":1559082720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-014-2314-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1007\/s00431-014-2314-6","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}